Interv Akut Kardiol. 2014;13(1):46

Novinky ve specifické léčbě plicní arteriální hypertenze

David Ambrož
II. interní klinika kardiologie a angiologie VFN a 1. LF UK, Praha

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ambrož D. Novinky ve specifické léčbě plicní arteriální hypertenze. Interv Akut Kardiol. 2014;13(1):46.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Galie N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension; Eur Heart J 2009; 30: 394-403. Go to original source... Go to PubMed...
    2. Pulido T, Adzerikho I, Channick RN, et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension; N. Engl J Med 2013; 369: 809-818. Go to original source... Go to PubMed...
    3. Nicolas LB, Gutierrez MM, Dingemanse J. Comparativepharmacokinetic, pharmacodynamic, safety, and tolerability profiles of 3 different formulations of epoprostenol sodium for injection in healthy men; Clin Ther 2013; 35: 440-449. Go to original source... Go to PubMed...
    4. Sitbon O1, Delcroix M2, Bergot E3, et al. EPITOME-2; An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension; Am Heart J 2014; 167: 210-217.

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.